US 7834024
Compositions and methods for inhibition of the JAK pathway
granted A61KA61K31/506A61K31/5375
Quick answer
US patent 7834024 (Compositions and methods for inhibition of the JAK pathway) held by Rigel Pharmaceuticals, Inc. expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/506, A61K31/5375, A61K31/538, A61K31/5383